Dr. John H. Hansen-Flaschen, MD

Dr. Hansen-Flaschen practices at Perelman Center for Advanced Medicine in Philadelphia, Pennsylvania.

Dr. Hansen-Flaschen's NPI, 1316971484, was assigned on July 11, 2006. Dr. Hansen-Flaschen graduated from New York University School of Medicine in 1976. Dr. Hansen-Flaschen holds Pennsylvania license MD020230E.

Dr. Hansen-Flaschen's primary practice is Perelman Center for Advanced Medicine, at 3400 Civic Center Blvd, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-7300.

Dr. Hansen-Flaschen's primary practice is Perelman Center for Advanced Medicine in Philadelphia, Pennsylvania. Dr. Hansen-Flaschen is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Hansen-Flaschen to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hansen-Flaschen practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Hansen-Flaschen's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Hansen-Flaschen is licensed in Pennsylvania.

CMS data shows 366 Medicare services from Dr. Hansen-Flaschen across 5 procedure codes in 2024, for 98 Medicare patients. Medicare paid $25,243 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 98 Medicare patients who saw Dr. Hansen-Flaschen in 2024. The largest group is 65 to 74, with 39 patients. 68% of them have high cholesterol, and 63% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hansen-Flaschen's median patient age at 67, with 57% women.

In 2024, Dr. Hansen-Flaschen wrote 539 Medicare Part D claims for 60 patients. 55% of them were for generic drugs. CMS names the drug for 360 of them, across 16 drugs with 11 or more claims each, at $239,071 in total drug cost. In 2023, CMS named 367 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Hansen-Flaschen for performance year 2024, reported as part of a group. Dr. Hansen-Flaschen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hansen-Flaschen as offering telehealth.

Dmand AI links 19 papers to Dr. Hansen-Flaschen, published from 2017 to 2023. 2023 was the busiest year, with 3. The most frequent topics are Respiratory Insufficiency, Dyspnea and Noninvasive Ventilation. Dr. Hansen-Flaschen has published most often in Ann Am Thorac Soc. Dr. Hansen-Flaschen's most frequent co-authors are Michelle Thi Cao, DO, Lauren B. Elman, MD and Steven Mark Kawut, MD.

CMS Open Payments shows 10 general payments to Dr. Hansen-Flaschen from 3 drug and device companies from 2018 to 2025. Device or supply loans make up the largest share, 100% of the total. Philips Electronics North America Corporation paid the most, $61,467.

Dr. Hansen-Flaschen graduated from New York University School of Medicine in 1976.